Tempus AI (NASDAQ:TEM) Shares Up 7.5% – Time to Buy?

Tempus AI, Inc. (NASDAQ:TEM)’s stock price traded up 7.5% during mid-day trading on Monday . The company traded as high as $55.70 and last traded at $55.9350. 2,339,854 shares traded hands during trading, a decline of 60% from the average session volume of 5,814,483 shares. The stock had previously closed at $52.05.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Lake Street Capital downgraded shares of Tempus AI to a “hold” rating in a research report on Monday, July 20th. HC Wainwright lowered their price objective on Tempus AI from $64.00 to $56.00 and set a “buy” rating on the stock in a research note on Monday, August 3rd. TD Cowen reaffirmed a “buy” rating on shares of Tempus AI in a report on Wednesday, July 15th. Freedom Capital upgraded Tempus AI to a “hold” rating in a research report on Tuesday, June 30th. Finally, BTIG Research reduced their target price on Tempus AI from $80.00 to $70.00 and set a “buy” rating on the stock in a report on Monday, August 3rd. Nine analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat.com, Tempus AI has an average rating of “Hold” and a consensus target price of $64.92.

Tempus AI Trading Up 1.1%

The business’s 50 day simple moving average is $51.49 and its two-hundred day simple moving average is $51.68. The stock has a market cap of $10.05 billion, a P/E ratio of -38.67 and a beta of 3.58. The company has a quick ratio of 3.16, a current ratio of 3.30 and a debt-to-equity ratio of 3.06.

Tempus AI (NASDAQ:TEM) last issued its quarterly earnings data on Thursday, July 30th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.14) by $0.10. The business had revenue of $382.49 million during the quarter, compared to analyst estimates of $379.69 million. Tempus AI had a negative net margin of 17.77% and a negative return on equity of 50.28%. The firm’s quarterly revenue was up 21.6% on a year-over-year basis. During the same quarter last year, the business earned ($0.22) EPS. As a group, analysts expect that Tempus AI, Inc. will post -1.38 EPS for the current year.

Insider Buying and Selling

In other Tempus AI news, Director Jennifer A. Doudna sold 2,673 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The stock was sold at an average price of $55.00, for a total value of $147,015.00. Following the transaction, the director directly owned 25,942 shares of the company’s stock, valued at approximately $1,426,810. The trade was a 9.34% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO James William Rogers sold 11,529 shares of the stock in a transaction on Thursday, June 25th. The stock was sold at an average price of $55.00, for a total transaction of $634,095.00. Following the transaction, the chief financial officer directly owned 114,866 shares in the company, valued at approximately $6,317,630. This represents a 9.12% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders sold 743,981 shares of company stock worth $35,880,242. Corporate insiders own 24.26% of the company’s stock.

Institutional Inflows and Outflows

A number of large investors have recently made changes to their positions in TEM. JPL Wealth Management LLC purchased a new stake in shares of Tempus AI in the third quarter worth approximately $26,000. Los Angeles Capital Management LLC bought a new position in shares of Tempus AI during the fourth quarter valued at about $27,000. Harvest Fund Management Co. Ltd bought a new position in shares of Tempus AI during the third quarter valued at about $38,000. Whittier Trust Co. boosted its holdings in Tempus AI by 190.0% during the first quarter. Whittier Trust Co. now owns 870 shares of the company’s stock worth $41,000 after purchasing an additional 570 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Tempus AI by 88.8% in the 2nd quarter. EverSource Wealth Advisors LLC now owns 691 shares of the company’s stock worth $44,000 after purchasing an additional 325 shares in the last quarter. 24.22% of the stock is owned by institutional investors.

Tempus AI Company Profile

Tempus is a technology-driven healthcare company that applies artificial intelligence and machine learning to clinical and molecular data in order to advance precision medicine. Its primary focus lies in oncology, where the company offers comprehensive genomic profiling, digital pathology services and data-driven insights to inform personalized cancer care. By integrating DNA and RNA sequencing with structured clinical information, Tempus enables clinicians and researchers to identify targeted treatment options for patients based on the genetic characteristics of their tumors.

The company’s core offering centers on a scalable, cloud-based analytics platform that aggregates vast amounts of molecular and clinical data.